Original language | English (US) |
---|---|
Pages (from-to) | e1-e29 |
Journal | Journal of the American College of Radiology |
Volume | 13 |
Issue number | 2 |
DOIs | |
State | Published - 2016 |
Externally published | Yes |
Keywords
- ACC appropriate use criteria
- ACR Appropriateness Criteria
- appropriate utilization
- chest pain
- imaging
- multimodality
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American College of Radiology, Vol. 13, No. 2, 2016, p. e1-e29.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients with Chest Pain :A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force
AU - Rybicki, Frank J.
AU - Udelson, James E.
AU - Peacock, W. Frank
AU - Goldhaber, Samuel Z.
AU - Isselbacher, Eric M.
AU - Kazerooni, Ella
AU - Kontos, Michael C.
AU - Litt, Harold
AU - Woodard, Pamela K.
AU - Alpert, Joseph S.
AU - Andrews, George A.
AU - Chen, Edward P.
AU - Cooke, David T.
AU - Cury, Ricardo C.
AU - Edmundowicz, Daniel
AU - Ferrari, Victor
AU - Graff, Louis G.
AU - Hollander, Judd E.
AU - Klein, Lloyd W.
AU - Leipsic, Jonathan
AU - Levy, Phillip D.
AU - Mahmarian, John J.
AU - Rosenberg, Craig
AU - Rubin, Geoffrey
AU - Ward, R. Parker
AU - White, Charles
AU - Yucel, E. Kent
AU - Carr, J. Jeffrey
AU - White, Richard D.
AU - Patel, Manesh
AU - Douglas, Pamela
AU - Hendel, Robert C.
AU - Kramer, Christopher
AU - Doherty, John
N1 - Funding Information: A standard exemption to the American College of Cardiology’s policy regarding relationships with industry is extended to appropriate use criteria writing committees that do not make recommendations but rather prepare background materials and typical clinical scenarios and indications that are rated independently by a separate rating panel. Participant Consultant Speakers Bureau Ownership/Partnership/Principal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Appropriate Utilization of Cardiovascular Imaging in ED Patients With CP Writing Group Frank J. Rybicki None None None ■ Toshiba Medical Systems ∗ None None James E. Udelson None None None None None None W. Frank Peacock ■ Alere ■ BG Medicine ■ Cardiorentis ∗ ■ Daiichi-Sankyo ■ Instrumentation Laboratories ■ Janssen ■ The Medicine’s Company ■ Novartis None ■ Comprehen-sive Research Associates ∗ ■ Alere ■ Critical Diagnostics ■ The Medicine’s Company ∗ ■ Roche ∗ None None Samuel Z. Goldhaber ■ Bayer ■ BMS ■ Boehringer Ingelheim ■ Daiichi -Sankyo ∗ ■ Janssen ■ Merck ■ Pfizer ■ Portola None None ■ BMS ∗ ■ BTG ∗ ■ Daiichi -Sankyo ∗ ■ NHLBI ∗ ■ Thrombosis Research Institute None None Eric M. Isselbacher None None None None None None Ella Kazerooni None None None None None None Michael C. Kontos None None None None None None Harold Litt ■ HeartFlow, Inc None None ■ Siemens Medical Solutions None None Pamela K. Woodard None None None None None None Appropriate Utilization of Cardiovascular Imaging in ED Patients With CP Rating Panel Joseph S. Alpert None None None None None None George A. Andrews None None None None ■ Humana, Inc (employee) ∗ None Edward P. Chen ■ Medtronic None None None None None David T. Cooke None None None None None None Ricardo C. Curry ■ Astellas ∗ ■ GE Healthcare ∗ None None ■ Astellas ∗ ■ GE Healthcare ∗ None None Daniel Edmundowicz None None None None None None Victor Ferrari None None None None ■ Society for Cardiovascular Magnetic Resonance None Louis G. Graff None None None None None None Judd E. Hollander ■ Behring ■ Instrumentation Laboratories ■ Janssen ■ Radiometer ∗ None None ■ Abbott ∗ ■ Alere ∗ ■ Brahms ∗ ■ Siemens ∗ None None Lloyd W. Klein None None None None None None Jonathan Leipsic ■ Edwards ∗ ■ GE Healthcare ■ GE Healthcare None ■ Heartflow ∗ None None Phillip D. Levy None None None None ■ Lantheus Medical Imaging ■ National Institutes of Health ∗ None John J. Mahmarian None None None None None None Craig Rosenberg None None None None None None Geoffrey Rubin None None None None None None R. Parker Ward None None None None None Charles White None None None None None None Appropriate Utilization of Cardiovascular Imaging in ED Patients With CP External Reviewers Fabian Bamberg None ■ Bayer ■ Siemens None None None None Dickson S. Cheung None None None None None None Jersey Chen None None None None ■ Agency for Healthcare Quality and Research None Resa Lewiss None None None None None None Michel Makaroun None None None None None None James McCord None None None ■ Roche ∗ ■ Society of CP Centers None Indu G. Poornima None None None ■ Astellas Pharma ∗ ■ GE Healthcare ∗ None None Gilbert L. Raff None None None ■ Siemens None None Leslee Shaw ■ Agency for Healthcare Quality and Research None None None None None Todd C. Villiness None None None None None None ACR Appropriate Utilization of Cardiovascular Imaging Oversight Committee E. Kent Yucel None None None None None None J. Jeffrey Carr None None None None ■ Society of Cardiovascular Computed Tomography None Frank J. Rybicki None None None None None None Richard D. White None None None None None None Pamela K. Woodard None None None ■ Astellas ∗ ■ Agency for Healthcare Quality and Research None ACC Appropriate Utilization of Cardiovascular Imaging Oversight Committee Manesh R. Patel None None None None None None Pamela S. Douglas None None None None None None Robert C. Hendel None None None None None None Christopher M. Kramer ■ St. Jude Medical None None None None None John U. Doherty None None None None None None This table represents the relevant relationships with industry and other entities that were disclosed by participants at the time of participation. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity or ownership of $10,000 or more of the fair market value of the business entity or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. Participation does not imply endorsement of this document. ∗ Significant (greater than $10,000) relationship.
PY - 2016
Y1 - 2016
KW - ACC appropriate use criteria
KW - ACR Appropriateness Criteria
KW - appropriate utilization
KW - chest pain
KW - imaging
KW - multimodality
UR - http://www.scopus.com/inward/record.url?scp=84955299887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955299887&partnerID=8YFLogxK
U2 - 10.1016/j.jacr.2015.07.007
DO - 10.1016/j.jacr.2015.07.007
M3 - Article
C2 - 26810814
AN - SCOPUS:84955299887
SN - 1546-1440
VL - 13
SP - e1-e29
JO - Journal of the American College of Radiology
JF - Journal of the American College of Radiology
IS - 2
ER -